Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lfx
    Junior Member
    • Jul 2010
    • 2

    #1

    Minimum number of transcripts in cufflinks GTF

    Hi all,

    Would like to know if there is a minimum number of transcripts required in a GTF file in order for cufflinks to run properly?

    I've also tried this with cuffdiff:-
    1) full genome GTF
    2) take 10 transcripts out of the full GTF

    the FPKMs seem to pile on in the results from the smaller GTF file.

    Am I doing something wrong? The reason I'm doing this is for screening some potentially novel transcripts / locations in the genome, and would likely be working with a much smaller set of GTF entries.

    Advise is much welcomed!!!
  • adarob
    Member
    • Jul 2010
    • 71

    #2
    FPKM is Fragments Per Kilobase per Million reads sequenced. Currently, Cufflinks calculates this "million reads sequenced" as "million reads mapped to the annotation", which is something we are looking at switching in the next version. To put the FPKMs on the same scale for the different runs, simply multiply the FPKMs by the "Total Map Mass" that Cufflinks prints to the screen. You can then divide by the number of reads from the full data and everything will be on the same scale.

    Comment

    • lfx
      Junior Member
      • Jul 2010
      • 2

      #3
      adarob, thank you for the clarification.

      does this mean the cuffdiff results have already taken this into account when computing fold change between 2 samples?

      because if each run has its own map mass and number of reads, then i would think that their fpkms will not be on the same scale.

      Comment

      • adarob
        Member
        • Jul 2010
        • 71

        #4
        Since they both are forced to use the same GTF in cuffdiff, they will be on the same scale.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...